Professor Basil Sharrack is consultant neurologist and honorary professor of clinical neurology at the Royal Hallamshire Hospital, Sheffield. His main areas of interest are neuro-inflammation and degeneration in MS, therapeutic clinical trials in MS, autologous haematopoietic stem cell transplantation (AHSCT) and cognitive rehabilitation for people with MS, and idiopathic intracranial hypertension.

Basil has authored over 90 peer reviewed original articles and received over £8 million in grants and income from commercial clinical trials. He plays a leading role in the design and conduct of MS clinical trials in the UK, which include the first gene therapy trial at Sheffield Teaching Hospitals NHS Foundation Trust and the first phase III AHSCT treatment in patients with MS. Funding sources are the MS Society, National Institute of Health Research, and Biogen.
Basil is the director of the Sheffield MS Research Clinic. He is also chair of the Sheffield Research Ethics Committee and a member of the EBMT Autoimmune Diseases Working Party.

Watch video:

• Webinar: AHSCT for highly active and rapidly evolving severe MS during the COVID-19 pandemic